Novavax’s Covid-19 vaccine shows promising immune response, early data show
The trial shows the vaccine "may be a potential winner, but efficacy and safety studies need to continue,” one expert said.
Read The StoryBiotech
Inside the discoveries, personalities, and deals driving drug development. Sign up for The Readout newsletter to get the latest on biotech delivered to your inbox. And subscribe to STAT Plus to access daily, market-moving coverage of the biotech sector — from startup funding to clinical trial readouts
First data for Moderna Covid-19 vaccine show it spurs an immune response
CytoDyn CEO claims Covid-19 drug success while describing data suggesting study failure
Gilead announces long-awaited price for Covid-19 drug remdesivir
Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups
All Coverage
advertisement
